{"data":{"id":"us-me/22-m.r.s.-2673","jurisdiction":"us-me","citation":"22 M.R.S. §2673","heading":"Action against health care practitioner or health care provider license prohibited","body":"A licensing board may not revoke, refuse to renew or suspend the license of or take any action against a health care practitioner as defined in Title 24, section 2502, subsection 1‑A based solely on the health care practitioner's recommendations to an eligible patient regarding access to or treatment with an investigational drug, biological product or device, as long as the recommendations are consistent with medical standards of care.\nThe licensing agency may not revoke, refuse to renew or suspend the license of or take any action against a health care provider as defined in Title 24, section 2502, subsection 2 based solely on the health care provider’s involvement in the care of an eligible patient using an investigational drug, biological product or device.","path":["TITLE 22: HEALTH AND WELFARE","SUBTITLE 2: HEALTH","PART 5: FOODS AND DRUGS","CHAPTER 602-A: ACCESS TO INVESTIGATIONAL TREATMENTS FOR TERMINALLY ILL PATIENTS"],"source_url":"https://legislature.maine.gov/statutes/22/title22sec2673.html","current_through":"January 1, 2026","vintage":"","retrieved_at":"2026-09-04T15:12:31Z","sha256":"a2f7fe3d8de20683a97a78a628d82f188a7ef6bac15b21594889c1442692260a","source_id":"us-me","stale":false,"prev":"us-me/22-m.r.s.-2672","next":"us-me/22-m.r.s.-2674"},"notice":"GroundRules: Original legal text. Not legal advice."}